Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel
The BEF NETUEs Guide available now
Aids practitioners treating competition horses

The British Equine Federation (BEF) National Therapeutic Use Exemptions (NETUEs) Guide is now available to help practitioners who are treating horses under BEF or FEI regulations.

At FEI events, if a horse needs treatment, permission must be obtained from the Veterinary Delegate or, if it is a major event, the Veterinary Commission.

In competitions under national rules, however, there is no Veterinary Delegate equivalent and the Person Responsible (PR) must instead decide as to whether a horse that has been treated with a prohibited substance will compete.

At national level, the PR for a horse which requires treatment with a Controlled Medication Substance at or close to competition, should discuss the competition with the treating vet so that, if possible, medications can be used that will no longer be present in the horse's system by the time of competition.

When a Controlled Medication Substance is administered, the treating vet should complete a National Equine Therapeutic Use Exemption (NETUE) Medication form, and the PR then has ten working days with which to apply for an NETUE in full, using the BEFAR NETUE form.

The BEF Guide is available in full here.

Become a member or log in to add this story to your CPD history

Annual submission deadline small pet animal exemptions

News Story 1
 Companies marketing medicines for small pets exempt from authorisation must submit their annual return to the Veterinary Medicines Directorate (VMD) by 30 November 2026.

Submitting this annual return ensures continued compliance with regulatory requirements for products marketed without a full Marketing Authorisation. The exemption specifically applies to products intended for animals, cage birds, terrarium animals, small rodents, ferrets and rabbits.

For further details and submission guidelines, visit the gov.uk website.  

Click here for more...
News Shorts
BVA urges 'continued vigilance' over bluetongue

The British Veterinary Association (BVA) has urged vigilance following a concerning rise in Bluetongue (BTV) cases in sheep and cattle.

In a recent statement, the BVA noted that members are reporting more severe clinical signs and higher mortality rates than in previous years.

'We know that farm vets are working hard to support farmers and animals affected by this outbreak, during what is an extremely difficult time for all involved,' they stated. 'Continued vigilance to identify disease early is vital and vaccination remains the best way of protecting animals from this disease.'